Rumination-focused cognitive behaviour therapy vs. cognitive behaviour therapy for depression: study protocol for a randomised controlled superiority trial

Morten Hvenegaard, Ed R Watkins, Stig Poulsen, Nicole K Rosenberg, Matthias Gondan, Ben Grafton, Stephen F Austin, Henriette Howard, Stine B Moeller, Morten Hvenegaard, Ed R Watkins, Stig Poulsen, Nicole K Rosenberg, Matthias Gondan, Ben Grafton, Stephen F Austin, Henriette Howard, Stine B Moeller

Abstract

Background: Cognitive behavioural therapy is an effective treatment for depression. However, one third of the patients do not respond satisfactorily, and relapse rates of around 30 % within the first post-treatment year were reported in a recent meta-analysis. In total, 30-50 % of remitted patients present with residual symptoms by the end of treatment. A common residual symptom is rumination, a process of recurrent negative thinking and dwelling on negative affect. Rumination has been demonstrated as a major factor in vulnerability to depression, predicting the onset, severity, and duration of future depression. Rumination-focused cognitive behavioural therapy is a psychotherapeutic treatment targeting rumination. Because rumination plays a major role in the initiation and maintenance of depression, targeting rumination with rumination-focused cognitive behavioural therapy may be more effective in treating depression and reducing relapse than standard cognitive behavioural therapy.

Method/design: This study is a two-arm pragmatic randomised controlled superiority trial comparing the effectiveness of group-based rumination-focused cognitive behaviour therapy with the effectiveness of group-based cognitive behavioural therapy for treatment of depression. One hundred twenty-eight patients with depression will be recruited from and given treatment in an outpatient service at a psychiatric hospital in Denmark. Our primary outcome will be severity of depressive symptoms (Hamilton Rating Scale for Depression) at completion of treatment. Secondary outcomes will be level of rumination, worry, anxiety, quality of life, behavioural activation, experimental measures of cognitive flexibility, and emotional attentional bias. A 6-month follow-up is planned and will include the primary outcome measure and assessment of relapse.

Discussion: The clinical outcome of this trial may guide clinicians to decide on the merits of including rumination-focused cognitive behavioural therapy in the treatment of depression in outpatient services.

Trial registration: ClinicalTrials.gov Identifier: NCT02278224 , registered 28 Oct. 2014.

References

    1. Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord. 2014;159:118–26. doi: 10.1016/j.jad.2014.02.026.
    1. McDermut W, Miller IW, Brown RA. The efficacy of group psychotherapy for depression: a meta-analysis and review of the empirical research. Clin Psychol Sci Pract. 2006;8:98–116. doi: 10.1093/clipsy.8.1.98.
    1. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26:17–31. doi: 10.1016/j.cpr.2005.07.003.
    1. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006;74:658–70. doi: 10.1037/0022-006X.74.4.658.
    1. Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36:427–40. doi: 10.1007/s10608-012-9476-1.
    1. Kennedy N, Paykel ES. Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord. 2004;80:135–44. doi: 10.1016/S0165-0327(03)00054-5.
    1. Riso LP, du Toit PL, Blandino J a, Penna S, Dacey S, Duin JS. Cognitive aspects of chronic depression. J Abnorm Psychol. 2003;112:72–80. doi: 10.1037/0021-843X.112.1.72.
    1. Van Rijsbergen GD, Kok GD, Elgersma HJ, Hollon SD, Bockting CLH. Personality and cognitive vulnerability in remitted recurrently depressed patients. J Affect Disord. 2015;173:97–104. doi: 10.1016/j.jad.2014.10.042.
    1. Beshai S, Dobson KS, Bockting CLH, Quigley L. Relapse and recurrence prevention in depression: current research and future prospects. Clin Psychol Rev. 2011;31:1349–60. doi: 10.1016/j.cpr.2011.09.003.
    1. Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive–behavioral therapy’s effects. J Consult Clin Psychol. 2007;75:475–88. doi: 10.1037/0022-006X.75.3.475.
    1. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999;56:829–35. doi: 10.1001/archpsyc.56.9.829.
    1. Jarrett RB, Vittengl JR, Clark LA. How much cognitive therapy, for which patients, will prevent depressive relapse? J Affect Disord. 2008;111:185–92. doi: 10.1016/j.jad.2008.02.011.
    1. Watkins ER. Depressive rumination: investigating mechanisms to improve cognitive behavioural treatments. Cogn Behav Ther. 2009;38(Suppl 1):8–14. doi: 10.1080/16506070902980695.
    1. Watkins ER, Scott J, Wingrove J, Rimes K, Bathurst N, Steiner H, et al. Rumination-focused cognitive behaviour therapy for residual depression: a case series. Behav Res Ther. 2007;45:2144–54. doi: 10.1016/j.brat.2006.09.018.
    1. Smith JM, Alloy LB. A roadmap to rumination: a review of the definition, assessment, and conceptualization of this multifaceted construct. Clin Psychol Rev. 2009;29:116–28. doi: 10.1016/j.cpr.2008.10.003.
    1. Nolen-Hoeksema S, Wisco BE, Lyubomirsky S. Rethinking Rumination. Perspect Psychol Sci. 2008;3:400–24. doi: 10.1111/j.1745-6924.2008.00088.x.
    1. Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J Abnorm Psychol. 2000;109:504–11. doi: 10.1037/0021-843X.109.3.504.
    1. Watkins ER, Mullan E, Wingrove J, Rimes K, Steiner H, Bathurst N, et al. Rumination-focused cognitive-behavioural therapy for residual depression: phase II randomised controlled trial. Br J Psychiatry. 2011;199:317–22. doi: 10.1192/bjp.bp.110.090282.
    1. Wells A, Fisher P, Myers S, Wheatley J, Patel T, Brewin CR. Metacognitive therapy in recurrent and persistent depression: a multiple-baseline study of a new treatment. Cognit Ther Res. 2009;33:291–300. doi: 10.1007/s10608-007-9178-2.
    1. Teismann T, von Brachel R, Hanning S, Grillenberger M, Hebermehl L, Hornstein I, et al. A randomized controlled trial on the effectiveness of a rumination-focused group treatment for residual depression. Psychother Res. 2014;24:80–90. doi: 10.1080/10503307.2013.821636.
    1. Watkins ER. Constructive and unconstructive repetitive thought. Psychol Bull. 2008;134:163–206. doi: 10.1037/0033-2909.134.2.163.
    1. Martell CR, Addis ME, Jacobson NS. Depression in Context: Strategies for Guided Action. New York: W. W. Norton & Company, Inc.; 2001.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.
    1. Bukh JD, Bock C, Vinberg M, Gether U, Kessing LV. Clinical utility of Standardised Assessment of Personality - Abbreviated Scale (SAPAS) among patients with first episode depression. J Affect Disord. 2010;127:199–202. doi: 10.1016/j.jad.2010.05.023.
    1. Jacobson NS, Martell CR, Dimidjian S. Behavioral activation treatment for depression: returning to contextual roots. Clin Psychol Sci Pract. 2001;8:255–70. doi: 10.1093/clipsy.8.3.255.
    1. Beck AT, Rush J, Shaw B, Emery G. Cognitive Therapy of Depression. New York: The Guilford Press; 1979.
    1. Watkins ER, Taylor RS, Byng R, Baeyens C, Read R, Pearson K, et al. Guided self-help concreteness training as an intervention for major depression in primary care: a Phase II randomized controlled trial. Psychol Med. 2012;42:1359–71. doi: 10.1017/S0033291711002480.
    1. Csikszentmihalyi M. Flow: The Psychology of Optimal Performance. New York: HarperCollins; 1990.
    1. Gilbert P. The Compassionate Mind: A New Approach to Life’s Challenges. Oakland, CA 91609: New Harbinger Publications; 2010
    1. Young J, Beck AT. Cognitive therapy scale: Rating manual. Univ Pennsylvania, Philadelphia: Unpubl manuscript; 1980.
    1. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–96. doi: 10.1111/j.2044-8260.1967.tb00530.x.
    1. Bech P, Wilson P, Wessel T, Lunde M, Fava M. A validation analysis of two self-reported HAM-D 6 versions. Acta Psychiatr Scand. 2009;119:298–303. doi: 10.1111/j.1600-0447.2008.01289.x.
    1. Kanter JW, Rusch LC, Busch AM, Sedivy SK. Validation of the behavioral activation for depression scale (BADS) in a community sample with elevated depressive symptoms. J Psychopathol Behav Assess. 2009;31:36–42. doi: 10.1007/s10862-008-9088-y.
    1. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the penn state worry questionnaire. Behav Res Ther. 1990;28:487–95. doi: 10.1016/0005-7967(90)90135-6.
    1. Nolen-Hoeksema S, Morrow J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta Earthquake. J Pers Soc Psychol. 1991;61:115–21. doi: 10.1037/0022-3514.61.1.115.
    1. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: The gad-7. Arch Intern Med. 2006;166:1092–7. doi: 10.1001/archinte.166.10.1092.
    1. Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsl. 2004;32:15–6.
    1. Gaudino E, Geisler M, Squires N. Construct validity in the trail making test: what makes part B harder? J Clin Exp Neuropsychol. 1995;17:529–35. doi: 10.1080/01688639508405143.
    1. MacLeod C, Mathews A, Tata P. Attentional bias in emotional disorders. J Abnorm Psychol. 1986;95:15–20. doi: 10.1037/0021-843X.95.1.15.
    1. Cohen J. Statistical power analysis. Curr Dir Psychol Sci. 1992;1:98–101. doi: 10.1111/1467-8721.ep10768783.
    1. Lewis JA. Statistical principles for clinical trials (ICH E9): An introductory note on an international guideline. Stat Med. 1999;18:1903–4. doi: 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>;2-F.
    1. Schulz KF, Altman DG, Moher D, CONSORT Group 2010 statement: Updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011;9:672–7. doi: 10.1016/j.ijsu.2011.09.004.
    1. World Medical Association World Medical Association Declaration of Helsinki Ethical Principles for medical research involving human subjects. JAMA. 2013;310:2191–4. doi: 10.1001/jama.2013.281053.
    1. Ciesla JA, Roberts JE. Self-directed thought and response to treatment for depression: a preliminary investigation. J Cogn Psychother. 2002;16:435–53. doi: 10.1891/jcop.16.4.435.52528.
    1. Schmaling KB, Dimidjian S, Katon W, Sullivan M. Response styles among patients with minor depression and dysthymia in primary care. J Abnorm Psychol. 2002;111:350–6. doi: 10.1037/0021-843X.111.2.350.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다